Helicobacter pylori eradication lowers serum asymmetric dimethylarginine levels

Mediators of Inflammation

Volumn 2010, Issue , 2010, Pages

  Aydemir, Selim ^a   Eren, Hac ^a   Tekin, Ishak Ozel ^a   Harmandar, Ferda Akbay ^a   Demircan, Nejat ^a   Cabuk, Mehmet ^a  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; N(G),N(G) DIMETHYLARGININE; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; ANTIINFECTIVE AGENT; ARGININE; DRUG DERIVATIVE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENZYME INHIBITOR; N,N DIMETHYLARGININE; N,N-DIMETHYLARGININE; NOS3 PROTEIN, HUMAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT DURATION; ATHEROSCLEROSIS; BLOOD; CARDIOVASCULAR MALFORMATION; CLINICAL TRIAL; DRUG ANTAGONISM; MIDDLE AGED; PATHOGENICITY;

HELICOBACTER PYLORI;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ARGININE; ATHEROSCLEROSIS; CARDIOVASCULAR ABNORMALITIES; CLARITHROMYCIN; ENZYME INHIBITORS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; YOUNG ADULT;

EID: 79251535598     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2010/685903     Document Type: Article

References (43)

1. Ayada K., Yokota K., Kobayashi K., Shoenfeld Y., Matsuura E., Oguma K., Chronic infections and atherosclerosis Annals of the New York Academy of Sciences 2007 1108 594 602
2. Danesh J., Collins R., Peto R., Chronic infections and coronary heart disease: is there a link? Lancet 1997 350 9075 430 436
3. Epstein S. E., Zhou Y. F., Zhu J., Infection and atherosclerosis: emerging mechanistic paradigms Circulation 1999 100 4 e20 e28
4. Kanbay M., Gur G., Yucel M., Yilmaz U., Boyacioglu S., Does eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels? Digestive Diseases and Sciences 2005 50 7 1228 1231
5. Roussos A., Philippou N., Gourgoulianis K. I., Helicobacter pylori infection and respiratory diseases: a review World Journal of Gastroenterology 2003 9 1 5 8
6. Wyle F. A., Helicobacter pylori: current perspectives Journal of Clinical Gastroenterology 1991 13 1 S114 S124
7. Misiewicz J. J., Current insights in the pathogenesis of Helicobacter pylori infection European Journal of Gastroenterology and Hepatology 1995 7 7 701 703
8. Brown L. M., Helicobacter pylori: epidemiology and routes of transmission Epidemiologic Reviews 2000 22 2 283 297
9. Leontiadis G. I., Sharma V. K., Howden C. W., Non-gastrointestinal tract associations of Helicobacter pylori infection: what is the evidence? Archives of Internal Medicine 1999 159 9 925 940
10. Pellicano R., Fagoonee S., Rizzetto M., Ponzetto A., Helicobacter pylori and coronary heart disease: which directions for future studies? Critical Reviews in Microbiology 2003 29 4 351 359
11. Zhang Z., Zou Y. Y., Zhou Y., Zhou H., Li Y. J., The aggravatory effect of nicotine on Helicobacter pylori -induced gastric mucosa injury: role of asymmetric dimethylarginine Journal of Clinical Gastroenterology 2009 43 3 261 266
12. Selcuk M. T., Selcuk H., Temizhan A., et al. The effect of plasma asymmetric dimethylarginine (ADMA) level and L-arginine/ADMA ratio on the development of coronary collaterals Turk Kardiyoloji Dernegi Arsivi 2008 36 3 150 155
13. Landmesser U., Drexler H., The clinical significance of endothelial dysfunction Current Opinion in Cardiology 2005 20 6 547 551
14. Murohara T., Asahara T., Silver M., Bauters C., Masuda H., Kalka C., Kearney M., Chen D., Chen D., Symes J. F., Fishman M. C., Huang P. L., Isner J. M., Nitric oxide synthase modulates angiogenesis in response to tissue ischemia Journal of Clinical Investigation 1998 101 11 2567 2578
15. Amano K., Matsubara H., Iba O., Okigaki M., Fujiyama S., Imada T., Kojima H., Nozawa Y., Kawashima S., Yokoyama M., Iwasaka T., Enhancement of ischemia-induced angiogenesis by eNOS overexpression Hypertension 2003 41 1 156 162
16. Smith R. S. Jr., Lin K. F., Agata J., Chao L., Chao J., Human endothelial nitric oxide synthase gene delivery promotes angiogenesis in a rat model of hindlimb ischemia Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 8 1279 1285
17. Papapetropoulos A., Garcia-Cardena G., Madri J. A., Sessa W. C., Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells Journal of Clinical Investigation 1997 100 12 3131 3139
18. Leiper J., Vallance P., Biological significance of endogenous methylarginines that inhibit nitric oxide synthases Cardiovascular Research 1999 43 3 542 548
19. Vallance P., Leone A., Calver A., Collier J., Moncada S., Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure Lancet 1992 339 8793 572 575
20. Marra M., Bonfigli A. R., Bonazzi P., Galeazzi R., Sirolla C., Testa I., Cenerelli S., Boemi M., Testa R., Asymptomatic Helicobacter pylori infection increases asymmetric dimethylarginine levels in healthy subjects Helicobacter 2005 10 6 609 614
21. Boger R. H., Bode-Boger S. M., Szuba A., Tsao P. S., Chan J. R., Tangphao O., Blaschke T. F., Cooke J. P., Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia Circulation 1998 98 18 1842 1847
22. Miyazaki H., Matsuoka H., Cooke J. P., Usui M., Ueda S., Okuda S., Imaizumi T., Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis Circulation 1999 99 9 1141 1146
23. Valkonen V. P., Paiva H., Salonen J. T., Lakka T. A., Lehtimaki T., Laakso J., Laaksonen R., Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine Lancet 2001 358 9299 2127 2128
24. Schweeger I., Fitscha P., Sinzinger H., Successful eradication of Helicobacter pylori as determined by 13 C- urea breath test does not alter fibrinogen and acute phase response markers Thrombosis Research 2000 97 6 411 420
25. Kielstein J. T., Fliser D., Veldink H., Asymmetric dimethylarginine and symmetric dimethylarginine: axis of evil or useful alliance? Seminars in Dialysis 2009 22 4 346 350
26. Boger R. H., Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond Annals of Medicine 2006 38 2 126 136
27. Boger R. H., The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor Cardiovascular Research 2003 59 4 824 833
28. Schulze F., Wesemann R., Schwedhelm E., Sydow K., Albsmeier J., Cooke J. P., Boger R. H., Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay Clinical Chemistry and Laboratory Medicine 2004 42 12 1377 1383
29. Zoccali C., Bode-Boger S. M., Mallamaci F., Benedetto F. A., Tripepi G., Malatino L. S., Cataliotti A., Bellanuova I., Fermo I., Frlich J. C., Boger R. H., Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study Lancet 2001 358 9299 2113 2117
30. Lu T. M., Ding Y. A., Lin S. J., Lee W. S., Tai H. C., Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention European Heart Journal 2003 24 21 1912 1919
31. Brown M. S., Goldstein J. L., Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis Annual Review of Biochemistry 1983 52 223 261
32. Witztum J. L., Horkko S., The role of oxidized LDL in atherogenesis: immunological response and anti-phospholipid antibodies Annals of the New York Academy of Sciences 1997 811 88 99
33. Suda O., Tsutsui M., Morishita T., Tasaki H., Ueno S., Nakata S., Tsujimoto T., Toyohira Y., Hayashida Y., Sasaguri Y., Ueta Y., Nakashima Y., Yanagihara N., Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 9 1682 1688
34. Delles C., Schneider M. P., John S., Gekle M., Schmieder R. E., Angiotensin converting enzyme inhibition and angiotensin II AT-receptor blockade reduce the levels of asymmetrical N, N-dimethylarginine in human essential hypertension American Journal of Hypertension 2002 15 7 590 593
35. Jia S. J., Jiang D. J., Hu C. P., Zhang X. H., Deng H. W., Li Y. J., Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells Vascular Pharmacology 2006 44 3 143 148
36. Enarsson K., Brisslert M., Backert S., Quiding-Jarbrink M., Helicobacter pylori induces transendothelial migration of activated memory T cells Infection and Immunity 2005 73 2 761 769
37. Eid H. M. A., Lyberg T., Arnesen H., Seljeflot I., Insulin and adiponectin inhibit the TNF -induced ADMA accumulation in human endothelial cells. The role of DDAH Atherosclerosis 2007 194 2 e1 e8
38. Aparicio J. R., Viedma J. A., Aparisi L., Navarro S., Martnez J., Prez-Mateo M., Helicobacter pylori eradication attenuates oxidative stress in human gastric mucosa American Journal of Gastroenterology 2001 96 6 1758 1766
39. Keenan J. I., Peterson R. A., Hampton M. B., NADPH oxidase involvement in the pathology of Helicobacter pylori infection Free Radical Biology and Medicine 2005 38 9 1188 1196
40. Augusto A. C., Miguel F., Mendonca S., Pedrazzoli J., Gurgueira S. A., Oxidative stress expression status associated to Helicobacter pylori virulence in gastric diseases Clinical Biochemistry 2007 40 9-10 615 622
41. Wadstrom T., Rydberg J., Rozalska B., Lelwala-Guruge J., Intravenous Helicobacter pylori induces low levels of TNF- and IL-1- in a murine model APMIS 1994 102 1 49 52
42. Fandriks L., Von Bothmer C., Johansson B., Holm M., Bolin I., Pettersson A., Water extract of Helicobacter pylori inhibits duodenal mucosal alkaline secretion in anesthetized rats Gastroenterology 1997 113 5 1570 1575
43. Ameriso S. F., Fridman E. A., Leiguarda R. C., Sevlever G. E., Detection of Helicobacter pylori in human carotid atherosclerotic plaques Stroke 2001 32 2 385 391